Pfizer announced Thursday that a third shot of its COVID-19 vaccine raised omicron-fighting antibody by 36 times in children ages 5 to 11. Pfizer/BioNTech plans to request emergency use authorization ...

A third dose of the Pfizer/BioNTech COVID-19 vaccine can "strongly" boost protection against the delta variant -- beyond the protection afforded by the standard two doses, suggests new data released ...

The Food and Drug Administration will likely authorize Pfizer's COVID-19 booster shot for adolescents aged 12 to 15 by next week, The Washington Post and The New York Times reported on Thursday. The ...

Pfizer and BioNTech said Wednesday that initial lab tests show that the omicron variant partly escapes protection offered by the companies' two-dose regimen of their COVID-19 vaccine. However, those ...

The US Food and Drug Administration (FDA) announced late Wednesday afternoon that it plans to hold an advisory committee meeting on 17 September to discuss a third booster shot of the Pfizer-BioNTech ...

A key advisory panel to the Centers for Disease Control and Prevention (CDC) voted Thursday to endorse the administration of Pfizer’s COVID-19 booster shots to those 65 and older, nursing home ...

WASHINGTON - A panel of advisers to the U.S. Centers for Disease Control and Prevention on Thursday continued discussing specific recommendations about who should get Pfizer’s COVID-19 booster shot — ...

The Food and Drug Administration has issued approval for a booster shot of Pfizer's COVID-19 vaccine for children as young as 12. The Pfizer vaccine is the first booster shot to receive emergency ...